1 day ago
11
People at high risk of developing rheumatoid arthritis (RA) may be able to postpone the disease for years with early treatment, according to new research from King's College London. The study found that a one year course of the biologic drug abatacept significantly delayed the onset of rheumatoid arthritis, with benefits continuing long after treatment ended.
Published in The Lancet Rheumatology, the research extends findings from an earlier clinical ...
English (US) ·